Executive Insights for Life Sciences Innovators

Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.

Executive Insights for Life Sciences Innovators is a science podcast hosted by GeneCoda® Executive Search, with 27 episodes on record and a Required Pod Score of 80.

GeneCoda® Executive Search hosts Executive Insights for Life Sciences Innovators, a science show with 27 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Executive Insights for Life Sciences Innovators

  Mark Rutledge | World Precision Instruments - Advancing Preclinical Research Through Better Tools and Models

  Sep 30, 202627 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Mark Rutledge, President and CEO of World Precision Instruments. Mark discusses how evolving research needs are reshaping the tools and technologies used in preclinical science. The conversation explores the growing importance of more standardized and physiologically relevant in vitro models, including organ-on-chip applications, as researchers look for better ways to generate meaningful data earlier in development. Mark also shares perspective from his leadership experience across diagnostics, life sciences tools, and commercial organizations. He discusses how World Precision Instruments evaluates where to innovate, the role of customer insight in product development, and the challenges of leading an established scientific instrumentation company through changing research and market expectations. This episode was streamed live on YouTube on September 28, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Justin Byers | Axio BioPharma - Building the Data Foundation for AI-Ready Biomanufacturing

  Sep 15, 202627 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Justin Byers, Founder and CEO of Axio BioPharma. Justin discusses why the next generation of AI-enabled biomanufacturing depends on something more fundamental than better algorithms: better access to structured, contextualized process data. The conversation explores how fragmented information across labs, manufacturing sites, sponsors, and external partners can slow development, complicate tech transfer, and limit the value organizations can extract from AI. Justin also shares perspective from his career across analytical science, process development, commercialization, and company building. He discusses Axio BioPharma’s approach to connecting real-world laboratory execution with broader process knowledge, the challenges of transferring knowledge across organizational boundaries, and what life sciences leaders should consider as they prepare their manufacturing operations for more effective use of AI. This episode was streamed live on YouTube on September 14, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Dhruv Patwardhan | LuminOne - Accountable AI for Life Sciences Commercial Teams

  Aug 29, 202632 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dhruv Patwardhan, Founder of LuminOne. Dhruv discusses how AI can improve commercial decision-making in life sciences by helping teams make better use of fragmented market, account, and customer signals. The conversation explores where AI is genuinely useful today, why many implementations stall after the pilot stage, and how leaders can distinguish practical workflow improvements from impressive demonstrations that fail to change day-to-day execution. Dhruv also shares perspective from more than a decade in life sciences commercial leadership, including lessons on workflow design, source traceability, human oversight, and accountability. He explains why AI should support rather than replace human judgment, and what CEOs and commercial leaders should consider as AI becomes more deeply embedded in commercial organizations. This episode was streamed live on YouTube on August 28, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Pawel Krysiak | Jaya Biosciences - Gene Therapy for Neurodegeneration

  Jun 30, 202635 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Pawel Krysiak, President & CEO of Jaya Biosciences. Pawel discusses JayaBio’s work to develop CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia. The conversation explores JayaBio’s focus on lysosomal enzyme gene heterozygosity and how this approach may help identify patient subpopulations within diseases historically treated as broad, heterogeneous conditions. Pawel also shares perspective from more than 20 years across neurodegeneration, oncology, rare diseases, commercialization, market access, and company building, including lessons from orphan drug launches and the challenge of advancing differentiated science toward clinical development. This episode was streamed live on YouTube on June 29, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  David Pass | AltrixBio - Gut-Targeted Oral Therapy for Diabetes and Obesity

  Jun 16, 202621 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with David Pass, CEO and President of AltrixBio. David discusses AltrixBio’s work to advance AJN003, a once-daily, oral, gut-targeted therapeutic candidate being developed for type 2 diabetes, obesity, and related cardiometabolic conditions. The conversation explores how AltrixBio’s approach is inspired by the metabolic effects observed after bariatric surgery, and how a non-systemic oral therapy could address important gaps in today’s treatment landscape. David also shares perspective from more than 25 years across diabetes, obesity, cardiovascular disease, pharma, biotech, and digital health, including lessons from commercial leadership, company building, and advancing differentiated science toward the clinic. This episode was streamed live on YouTube on June 15, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes

Recent guests on Executive Insights for Life Sciences Innovators. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.